NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/13/2025
Back to search
Official data from USPTO
STEMIFAI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STEMIFAI
ST13
US500000098402987Class
42, 44
Filing
98402987
Registration
7790453
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
05/13/2025
Trademark type
Word
Nice classes
42, 44
Filing date
02/13/2024
Registration date
05/13/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2025
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/08/2023
First use in commerce
02/08/2023
Drawing code
4
Owner type
99
Owner location
Kearny, NJ
Examiner
CLARK,MICHAEL J.
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
GenetikaPlus Ltd.
Representatives
Roy D. Gross The Roy Gross Law Firm, LLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; Providing an online non-downloadable Internet-based system application featuring technology enabling users to collectanalyse and predict scientific information in the field of central nervous system diseases related cellsincluding information about the gene expressionRNA expressioninduced pluripotent stem cellneuron cellproteinsreceptors and clinical and or lab data and metadata; Providing temporary use of on-line non-downloadable software development tools for collectionanalysis and prediction of scientific information in the field of central nervous system diseases related cellsincluding information about the gene expressionRNA expressioninduced pluripotent stem cellneuron cellproteinsreceptors and clinical and or lab data and metadata
Class 44
Genetic testing for medical purposes; Medical diagnostic testingmonitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of central nervous system diseases; Medical testing services relating to the diagnosis and treatment of disease
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/13/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/25/2025
PUBO
PUBLISHED FOR OPPOSITION
03/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/19/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2025
ALIE
ASSIGNED TO LIE
01/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/17/2024
GNRT
NON-FINAL ACTION E-MAILED
09/17/2024
CNRT
NON-FINAL ACTION WRITTEN
09/17/2024
DOCK
ASSIGNED TO EXAMINER
09/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2024
NWAP
NEW APPLICATION ENTERED
02/13/2024
Continuous trademark protection
Get notified about every new filing that threatens STEMIFAI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.